The Nantes biotechnology company Ose Immunotherapeutics creates an international scientific council. Composed of Pr. Wolf-Hervé Fridman (University of Paris), Dr. Sophie Brouard (CRTI, Nantes), Dr. Bernard Malissen (CIML, Marseille), Pr. Miriam Merad (Mount Sinaï, New York), Pr. Charles Serhan ( Harvard, Boston) and Dr. Jennifer Wargo (MT Anderson Cancer Center, Houston), he will work in collaboration with the management team and will advise his Board of Directors on the strategy to be carried out on the scientific, medical, translational and development. Dominique Costantini, Managing Director of OSE Immunotherapeutics, explains: “In collaboration with the Ose team, this council will contribute to meeting the new issues and challenges of our research today and tomorrow to prepare the new growth phase of the company, dedicated to bringing new entities into our portfolio and developing our first-in-class and diversified preclinical products in immuno-oncology, immunology and inflammation”.
–
–
